Biophysical inhibition of synthetic vs. naturally-derived pulmonary surfactant preparations by polymeric nanoparticles

Biochimica et Biophysica Acta - Biomembranes

Volumn 1838, Issue 1 PARTB, 2014, Pages 474-481

  Beck Broichsitter, Moritz ^a   Ruppert, Clemens ^a   Schmehl, Thomas ^a   Günther, Andreas ^a   Seeger, Werner ^a  

^a JUSTUS LIEBIG UNIVERSITY   (Germany)

Author keywords

Biophysical inhibition; Polymeric nanoparticles; Pulmonary drug delivery; Pulmonary surfactant; Surface activity

Indexed keywords

ARTIFICIAL LUNG SURFACTANT; BERACTANT; LUNG SURFACTANT; LUSUPULTIDE; NANOPARTICLE; PHOSPHOLIPID; POLYSTYRENE; SURFACTANT PROTEIN B;

ADSORPTION; ANEMOMETRY; ARTICLE; BIOCHEMICAL COMPOSITION; BIOPHYSICS; CONCENTRATION RESPONSE; CONTROLLED STUDY; IC 50; LIGHT SCATTERING; LUNG FLUID; NANOPHARMACEUTICS; NONHUMAN; PARTICLE SIZE; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; SURFACE PROPERTY; SURFACE TENSION; TRANSMISSION ELECTRON MICROSCOPY; ZETA POTENTIAL;

EID: 84888148644     PISSN: 00052736     EISSN: 18792642     Source Type: Journal    
DOI: 10.1016/j.bbamem.2013.10.016     Document Type: Article

References (63)

1. M. Beck-Broichsitter, O.M. Merkel, and T. Kissel Controlled pulmonary drug and gene delivery using polymeric nano-carriers J. Control. Release 161 2012 214 224
2. M. Beck-Broichsitter, J. Gauss, C.B. Packhaeuser, K. Lahnstein, T. Schmehl, W. Seeger, T. Kissel, and T. Gessler Pulmonary drug delivery with aerosolizable nanoparticles in an ex vivo lung model Int. J. Pharm. 367 2009 169 178
3. J.C. Sung, D.J. Padilla, L. Garcia-Contreras, J.L. VerBerkmoes, D. Durbin, C.A. Peloquin, K.J. Elbert, A.J. Hickey, and D.A. Edwards Formulation and pharmacokinetics of self-assembled rifampicin nanoparticle systems for pulmonary delivery Pharm. Res. 26 2009 1847 1855
4. M. Beck-Broichsitter, J. Gauss, T. Gessler, W. Seeger, T. Kissel, and T. Schmehl Pulmonary targeting with biodegradable salbutamol-loaded nanoparticles J. Aerosol Med. 23 2010 47 57
5. E. Rytting, M. Bur, R. Cartier, T. Bouyssou, X. Wang, M. Krueger, C.M. Lehr, and T. Kissel In vitro and in vivo performance of biocompatible negatively-charged salbutamol-loaded nanoparticles J. Control. Release 141 2010 101 107
6. W.H. Roa, S. Azarmi, M.H.D.K. Al-Hallak, W.H. Finlay, A.M. Magliocco, and R. Loebenberg Inhalable nanoparticles, a non-invasive approach to treat lung cancer in a mouse model J. Control. Release 150 2011 49 55
7. A.M. Nyström, and B. Fadeel Safety assessment of nanomaterials: implications for nanomedicine J. Control. Release 161 2012 403 408
8. S. Sharifi, S. Behzadi, S. Laurent, M. Laird Forrest, P. Stroeve, and M. Mahmoudi Toxicity of nanomaterials Chem. Soc. Rev. 41 2012 2323 2343
9. P.J.A. Borm, and W. Kreyling Toxicological hazards of inhaled nanoparticles - potential implications for drug delivery J. Nanosci. Nanotechnol. 4 2004 521 531 (Pubitemid 39387404)
10. J.W. Card, D.C. Zeldin, J.C. Bonner, and E.R. Nestmann Pulmonary applications and toxicity of engineered nanoparticles Am. J. Physiol. 295 2008 L400 L411
11. C. Mühlfeld, B. Rothen-Rutishauser, F. Blank, D. Vanhecke, M. Ochs, and P. Gehr Interactions of nanoparticles with pulmonary structures and cellular responses Am. J. Physiol. 294 2008 L817 L829
12. L.A. Dailey, N. Jekel, L. Fink, T. Gessler, T. Schmehl, M. Wittmar, T. Kissel, and W. Seeger Investigation of the proinflammatory potential of biodegradable nanoparticle drug delivery systems in the lung Toxicol. Appl. Pharmacol. 215 2006 100 108 (Pubitemid 44118400)
13. O. Harush-Frenkel, M. Bivas-Benita, T. Nassar, C. Springer, Y. Sherman, A. Avital, Y. Altschuler, J. Borlak, and S. Benita A safety and tolerability study of differently-charged nanoparticles for local pulmonary drug delivery Toxicol. Appl. Pharmacol. 246 2010 83 90
14. S. Gill, R. Loebenberg, T. Ku, S. Azarmi, W. Roa, and E.J. Prenner Nanoparticles: characteristics, mechanisms of action, and toxicity in pulmonary drug delivery - a review J. Biomed. Nanotechnol. 3 2007 107 119 (Pubitemid 351877160)
15. Y.Y. Zuo, R.A.W. Veldhuizen, A.W. Neumann, N.O. Petersen, and F. Possmayer Current perspectives in pulmonary surfactant - inhibition, enhancement and evaluation Biochim. Biophys. Acta 1778 2008 1947 1977
16. C. Schleh, B. Rothen-Rutishauser, and W.G. Kreyling The influence of pulmonary surfactant on nanoparticulate drug delivery systems Eur. J. Pharm. Biopharm. 77 2011 350 352
17. J. Todoroff, and R. Vanbever Fate of nanomedicines in the lungs Curr. Opin. Colloid Interface Sci. 16 2011 246 253
18. C. Schleh, and J.M. Hohlfeld Interaction of nanoparticles with the pulmonary surfactant system Inhalation Toxicol. 21 S1 2009 97 103
19. J. Perez-Gil Structure of pulmonary surfactant membranes and films: the role of proteins and lipid-protein interactions Biochim. Biophys. Acta 1778 2008 1676 1695
20. F. Possmayer, S.B. Hall, T. Haller, N.O. Petersen, Y.Y. Zuo, J. Bernardino de la Serna, A.D. Postle, R.A.W. Veldhuizen, and S. Orgeig Recent advances in alveolar biology: some new looks at the alveolar interface Respir. Physiol. Neurobiol. 173S 2010 S55 S64
21. E.J. Cabre, L.M.S. Loura, A. Fedorov, J. Perez-Gil, and M. Prieto Topology and lipid selectivity of pulmonary surfactant protein SP-B in membranes: answers from fluorescence Biochim. Biophys. Acta 1818 2012 1717 1725
22. E. Keating, Y.Y. Zuo, S.M. Tadayyon, N.O. Petersen, F. Possmayer, and R.A.W. Veldhuizen A modified squeeze-out mechanism for generating high surface pressures with pulmonary surfactant Biochim. Biophys. Acta 1818 2012 1225 1234
23. M.S. Bakshi, L. Zhao, R. Smith, F. Possmayer, and N.O. Petersen Metal nanoparticle pollutants interfere with pulmonary surfactant function in vitro Biophys. J. 94 2008 855 868 (Pubitemid 351162452)
24. S. Tatur, and A. Badia Influence of hydrophobic alkylated gold nanoparticles on the phase behavior of monolayers of DPPC and clinical lung surfactant Langmuir 28 2012 628 639
25. C. Schleh, C. Muehlfeld, K. Pulskamp, A. Schmiedl, M. Nassimi, H.D. Lauenstein, A. Braun, N. Krug, V.J. Erpenbeck, and J.M. Hohlfeld The effect of titanium dioxide nanoparticles on pulmonary surfactant function and ultrastructure Respir. Res. 10 2009 90
26. Q. Fan, Y.E. Wang, X. Zhao, J.S.C. Loo, and Y.Y. Zuo Adverse biophysical effects of hydroxyapatite nanoparticles on natural pulmonary surfactant ACS Nano 5 2011 6410 6416
27. R.K. Harishchandra, M. Saleem, and H.J. Galla Nanoparticle interaction with model lung surfactant monolayers J. R. Soc. Interface 7 2010 S15 S26
28. A.K. Sachan, R.K. Harishchandra, C. Bantz, M. Maskos, R. Reichelt, and H.J. Galla High-resolution investigation of nanoparticle interaction with a model pulmonary surfactant monolayer ACS Nano 6 2012 1677 1687
29. D. Stuart, R. Lobenberg, T. Ku, S. Azarmi, L. Ely, W. Roa, and E.J. Prenner Biophysical investigation of nanoparticle interactions with lung surfactant model systems J. Biomed. Nanotechnol. 2 2006 245 252
30. T. Ku, S. Gill, R. Loebenberg, S. Azarmi, W. Roa, and E.J. Prenner Size dependent interactions of nanoparticles with lung surfactant model systems and the significant impact on surface potential J. Nanosci. Nanotechnol. 8 2008 2971 2978
31. P. Lai, S. Nathoo, T. Ku, S. Gill, S. Azarmi, W. Roa, R. Lobenberg, and E.J. Prenner Real-time imaging of interactions between dipalmitoylphosphatidylcholine monolayers and gelatin based nanoparticles using Brewster angle microscopy J. Biomed. Nanotechnol. 6 2010 145 152
32. M.H.D.K. Al-Hallak, S. Azarmi, C. Sun, P. Lai, E.J. Prenner, W.H. Roa, and R. Lobenberg Pulmonary toxicity of polysorbate-80-coated inhalable nanoparticles; in vitro and in vivo evaluation AAPS J. 12 2010 294 299
33. M. Beck-Broichsitter, C. Ruppert, T. Schmehl, A. Guenther, T. Betz, U. Bakowsky, W. Seeger, T. Kissel, and T. Gessler Biophysical investigation of pulmonary surfactant surface properties upon contact with polymeric nanoparticles in vitro Nanomedicine 7 2011 341 350
34. T. Curstedt, H. Joernvall, B. Robertson, T. Bergman, and P. Berggren Two hydrophobic low-molecular-mass protein fractions of pulmonary surfactant. Characterization and biophysical activity Eur. J. Biochem. 168 1987 255 262
35. S. Hawgood, B.J. Benson, J. Schilling, D. Damm, J.A. Clements, and R.T. White Nucleotide and amino acid sequences of pulmonary surfactant protein SP 18 and evidence for cooperation between SP 18 and SP 28-36 in surfactant lipid adsorption Proc. Natl. Acad. Sci. U. S. A. 84 1987 66 70 (Pubitemid 17013579)
36. P. Markart, C. Ruppert, F. Grimminger, W. Seeger, and A. Günther Fibrinolysis-inhibitory capacity of clot-embedded surfactant is enhanced by SP-B and SP-C Am. J. Physiol. Lung Cell. Mol. Physiol. 284 2003 L69 L76
37. H. Schaegger, and G. von Jagow Tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis for the separation of proteins in the range from 1 to 100 kDa Anal. Biochem. 166 1987 368 379 (Pubitemid 18004907)
38. M.M. Bradford A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding Anal. Biochem. 72 1976 248 254
39. A. Günther, R. Schmidt, A. Feustel, U. Meier, C. Pucker, M. Ermert, and W. Seeger Surfactant subtype conversion is related to loss of surfactant apoprotein B and surface activity in large surfactant aggregates. Experimental and clinical studies Am. J. Respir. Crit. Care Med. 159 1999 244 251 (Pubitemid 29036530)
40. C. Ruppert, C. Pucker, P. Markart, K. Seibold, A. Bagheri, F. Grimminger, W. Seeger, and A. Günther Impact of surface tension on the conversion rate of large to small surfactant aggregates Biophys. Chem. 104 2003 229 238 (Pubitemid 36794474)
41. E.G. Bligh, and W.J. Dyer A rapid method of total lipid extraction and purification Can. J. Biochem. 37 1959 911 917
42. G. Rouser, S. Fleischer, and A. Yamamoto Two dimensional thin layer chromatographic separation of polar lipids and determination of phospholipids by phosphorus analysis of spots Lipids 5 1970 494 496
43. Y. Tanaka, T. Takei, T. Aiba, K. Masuda, A. Kiuchi, and T. Fujiwara Development of synthetic lung surfactants J. Lipid Res. 27 1986 475 485 (Pubitemid 16051146)
44. G. Enhorning Pulsating bubble technique for evaluating pulmonary surfactant J. Appl. Physiol. 43 1977 198 203 (Pubitemid 8172688)
45. O. Blanco, and J. Perez-Gil Biochemical and pharmacological differences between preparations of exogenous natural surfactant used to treat Respiratory Distress Syndrome: role of the different components in an efficient pulmonary surfactant Eur. J. Pharmacol. 568 2007 1 15 (Pubitemid 46976910)
46. W. Seeger, C. Grube, A. Günther, and R. Schmidt Surfactant inhibition by plasma proteins: differential sensitivity of various surfactant preparations Eur. Respir. J. 6 1993 971 977 (Pubitemid 23221331)
47. W. Bernhard, J. Mottaghian, A. Gebert, G.A. Rau, H.H. von Der, and C.F. Poets Commercial versus native surfactants. Surface activity, molecular components, and the effect of calcium Am. J. Respir. Crit. Care Med. 162 2000 1524 1533
48. R.G. Spragg, J.F. Lewis, W. Wurst, D. Hafner, R.P. Baughman, M.D. Wewers, and J.J. Marsh Treatment of acute respiratory distress syndrome with recombinant surfactant protein C surfactant Am. J. Respir. Crit. Care Med. 167 2003 1562 1566 (Pubitemid 37363368)
49. R. Schmidt, C. Ruppert, P. Markart, N. Lubke, L. Ermert, N. Weissmann, A. Breithecker, M. Ermert, W. Seeger, and A. Günther Changes in pulmonary surfactant function and composition in bleomycin-induced pneumonitis and fibrosis Toxicol. Appl. Pharmacol. 195 2004 218 231 (Pubitemid 38293153)
50. M. Rüdiger, A. Tölle, W. Meier, and B. Rüstow Naturally derived commercial surfactants differ in composition of surfactant lipids and in surface viscosity Am. J. Physiol. Lung Cell. Mol. Physiol. 288 2005 L379 L383
51. D.A. Groneberg, C. Witt, U. Wagner, K.F. Chung, and A. Fischer Fundamentals of pulmonary drug delivery Respir. Med. 97 2003 382 387 (Pubitemid 36410606)
52. B.P. Binks Particles as surfactants: similarities and differences Curr. Opin. Colloid Interface Sci. 7 2002 21 41
53. H. Zhang, Y.E. Wang, Q. Fan, and Y.Y. Zuo On the low surface tension of lung surfactant Langmuir 27 2011 8351 8358
54. G. Pilcer, and K. Amighi Formulation strategy and use of excipients in pulmonary drug delivery Int. J. Pharm. 392 2010 1 19
55. A.E. Nel, L. Madler, D. Velegol, T. Xia, E.M.V. Hoek, P. Somasundaran, F. Klaessig, V. Castranova, and M. Thompson Understanding biophysicochemical interactions at the nano-bio interface Nat. Mater. 8 2009 543 557
56. C. Schulze, U.F. Schaefer, C.A. Ruge, W. Wohlleben, and C.M. Lehr Interaction of metal oxide nanoparticles with lung surfactant protein A Eur. J. Pharm. Biopharm. 77 2011 376 383
57. C.A. Ruge, J. Kirch, O. Canadas, M. Schneider, J. Perez-Gil, U.F. Schaefer, C. Casals, and C.M. Lehr Uptake of nanoparticles by alveolar macrophages is triggered by surfactant protein A Nanomedicine 7 2011 690 693
58. C.A. Ruge, U.F. Schaefer, J. Herrmann, J. Kirch, O. Canadas, M. Echaide, J. Perez-Gil, C. Casals, R. Mueller, and C.M. Lehr The interplay of lung surfactant proteins and lipids assimilates the macrophage clearance of nanoparticles PLoS One 7 2012 e40775
59. W. Norde Adsorption of proteins from solution at the solid-liquid interface Adv. Colloid Interface Sci. 25 1986 267 340
60. O. Blanco, A. Cruz, O.L. Ospina, E. Lopez-Rodriguez, L. Vazquez, and J. Perez-Gil Interfacial behavior and structural properties of a clinical lung surfactant from porcine source Biochim. Biophys. Acta 1818 2012 2756 2766
61. H. Zhang, Q. Fan, Y.E. Wang, C.R. Neal, and Y.Y. Zuo Comparative study of clinical pulmonary surfactants using atomic force microscopy Biochim. Biophys. Acta 1808 2012 1832 1842
62. W. Seeger, C. Thede, A. Günther, and C. Grube Surface properties and sensitivity to protein-inhibition of a recombinant apoprotein C-based phospholipid mixture in vitro-comparison to natural surfactant Biochim. Biophys. Acta 1081 1991 45 52
63. W. Seeger, A. Günther, and C. Thede Differential sensitivity to fibrinogen inhibition of SP-C- vs. SP-B-based surfactants Am. J. Physiol. Lung Cell. Mol. Physiol. 262 1992 L286 L291